Tennessee SB 1848: Controlled Substances - As enacted, authorizes additional healthcare providers to directly administer buprenorphine mono or buprenorphine without the use of naloxone; adds that prescribing a buprenorphine product to nursing mother or prescribing an injectable mono product does not restrict certain healthcare providers from prescribing a buprenorphine product for the treatment of opioid use disorder without naloxone. - Amends TCA Title 53, Chapter 11.

Status: Comp. became Pub. Ch. 753 (as of 2026-04-24)

State: Tennessee · Session: 114 · Bill: SB 1848

Subjects: Controlled Substances

Sponsors: Massey

View Tennessee SB 1848 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.